QURCAN THERAPEUTICS INC.
Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents (GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
QURCAN THERAPEUTICS INC.
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-04-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.qurcan.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Euro Google Apps For Business Register.com DNS Weebly Hosting
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Employees Featured
Founder
Investors List
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Seed Round - QurCan Therapeutics Inc.
FACIT
FACIT investment in Seed Round - QurCan Therapeutics Inc.
Ontario Centre of Innovation
Ontario Centre of Innovation investment in Seed Round - QurCan Therapeutics Inc.
MEDTEQ+
MEDTEQ+ investment in Seed Round - QurCan Therapeutics Inc.
Ontario Brain Institute
Ontario Brain Institute investment in Seed Round - QurCan Therapeutics Inc.
FACIT
FACIT investment in Seed Round - QurCan Therapeutics Inc.
Ramen Ventures
Ramen Ventures investment in Seed Round - QurCan Therapeutics Inc.
FACIT
FACIT investment in Seed Round - QurCan Therapeutics Inc.
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Seed Round - QurCan Therapeutics Inc.
UTEST
UTEST investment in Seed Round - QurCan Therapeutics Inc.
Official Site Inspections
http://www.qurcan.com
- Host name: pages-custom-25.weebly.com
- IP address: 199.34.228.73
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
More informations about "QurCan Therapeutics Inc."
QURCAN THERAPEUTICS
QurCan is focused on the discovery and development of breakthrough therapeutics enabled by its proprietary nanoparticle drug delivery technology called “ TERP ”.See details»
Advanced Delivery Technology - QURCAN THERAPEUTICS
We are committed to restoring health and transforming the lives of patients through the development of nanomedicine that requires the unique features of the TERP technology to …See details»
Management Team - QURCAN THERAPEUTICS
Mohammad Ali Amini Chief Executive Officer DVM, PhD: Shirley Wu Chief Scientific Officer PhD, Professor, FAAPS. John Reid Chief Business Officer PhD, MBA MORE >See details»
University of Toronto Early Stage Technology (UTEST) | QurCan ...
QurCan Therapeutics develops a novel theranostic technology with capability of detecting brain tumor at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves the …See details»
QurCan Therapeutics - Ontario Genomics
Nov 1, 2023 · QurCan Therapeutics (Toronto) is developing technology to boost the effectiveness of cancer-fighting medicines. What they’re doing: Using genomics innovation, QurCan has …See details»
University of Toronto Entrepreneurship | QurCan Therapeutics Inc ...
QurCan Therapeutics develops a novel theranostic technology with capability of detecting brain tumor at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves the …See details»
QurCan Therapeutics Inc. | Source From Ontario
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and tissue-selective drug delivery to extra-hepatic sites, including the …See details»
QurCan Therapeutics Inc. - LinkedIn
QurCan Therapeutics (formerly Nanology Labs Inc) is a biotechnology company using advanced nanoparticle drug-delivery technology to unleash the immense potential of next-generation …See details»
QurCan | Source From Ontario
Aug 30, 2022 · QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary nanoparticle platform. The platform technology enables …See details»
Qurcan Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy.See details»
Qurcan Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Qurcan Therapeutics Inc. of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
QurCan Therapeutics Inc. - Crunchbase Company Profile & Funding
QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy. Nanology Labs has designed and is …See details»
Innovation - QURCAN THERAPEUTICS
At QurCan Therapeutics, we have developed the next generation drug delivery platform technology "TERP" that overcomes the challenges of immunogenicity, low stability, rapid …See details»
Qurcan Therapeutics - Overview, News & Similar companies
View Qurcan Therapeutics (www.qurcan.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
QurCan Therapeutics | Ontario at Biotech Showcase 2023 | Source …
Dec 20, 2022 · QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics enabled by its proprietary nanoparticle drug delivery …See details»
TECHNOLOGY - QURCAN THERAPEUTICS
QurCan’s proprietary TERP technology has been engineered with a novel Polymer-Lipid surface chemistry to direct therapeutic payloads to tissue beyond the liver, including CNS and spleen. …See details»
QurCan Therapeutics - VentureRadar
Website: http://www.qurcan.com. Develops innovative nanoparticle technology for targeted delivery of therapeutics, addressing critical unmet needs in cancer and major disease …See details»
QurCan Therapeutics | Ontario at BIO 2023 - Source From Ontario
QurCan has two immunomodulatory cancer therapeutics in its pipeline and a strong IP portfolio. At BIO 2023, the company is seeking global partners to develop new RNA / DNA therapies …See details»
BioCreate Program - Ontario Genomics
BioCreate will provide funding, access to mentorship and business support to enable companies to raise additional financing to achieve commercial outcomes.See details»
QP
Our primary aim is to produce high quality publications serving the study of the Qur'an and facilitating free distribution of them worldwide.See details»